Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy.
暂无分享,去创建一个
R. J. Hodgkiss | H. Oppelaar | F. Stewart | A. J. van der Kogel | I. P. van Geel | P. Rijken | F. A. Stewart | R. Hodgkiss | H. Oppelaar | P. F. Rijken | H. J. Bernsen | N. E. Hagemeier | N. Hagemeier | H. Bernsen
[1] J. Gray,et al. A new mouse tumor model system (RIF-1) for comparison of end-point studies. , 1980, Journal of the National Cancer Institute.
[2] G. Wilson,et al. Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. , 1991, British Journal of Cancer.
[3] D. Chaplin,et al. The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: evidence for therapeutic gain. , 1987, International journal of radiation oncology, biology, physics.
[4] S. Fox,et al. TUMOUR ANGIOGENESIS , 1996, The Journal of pathology.
[5] M. Trotter,et al. The use of fluorescent probes to identify regions of transient perfusion in murine tumors. , 1989, International journal of radiation oncology, biology, physics.
[6] A. Rauth,et al. Oxygen tension, cellular respiration, and redox state as variables influencing the cytotoxicity of the radiosensitizer misonidazole. , 1982, Radiation research.
[7] C. Koch. Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin. , 1993, Cancer research.
[8] P. Okunieff,et al. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.
[9] M. Trotter,et al. Effect of vascular marker Hoechst 33342 on tumour perfusion and cardiovascular function in the mouse. , 1990, British Journal of Cancer.
[10] E. C. Beuvery,et al. Analysis of glycoforms present in two mouse IgG2a monoclonal antibody preparations. , 1992, Journal of immunological methods.
[11] M R Arnfield,et al. Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II. , 1991, Radiation research.
[12] H. Oppelaar,et al. Enhancement of interstitial photodynamic therapy by mitomycin C and EO9 in a mouse tumour model , 1994, International journal of cancer.
[13] A. Begg,et al. Fluorescent markers of hypoxic cells: a comparison of two compounds on three cell lines. , 1985, The British journal of radiology.
[14] P. Allen,et al. Nuclear magnetic resonance spectroscopy and sensitizer-adduct measurements of photodynamic therapy-induced ischemia in solid tumors. , 1991, Journal of the National Cancer Institute.
[15] T. Mang,et al. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. , 1985, Cancer research.
[16] L. H. Gray,et al. The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.
[17] T. Oostendorp,et al. Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse. , 1995, British Journal of Cancer.
[18] G. Adams,et al. Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145. , 1992, British Journal of Cancer.
[19] R. Moore,et al. Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123-iodoazomycin arabinoside. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] W. Star,et al. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. , 1986, Cancer research.
[21] A. J. van der Kogel,et al. Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. , 1995, Microvascular research.
[22] R. Mulcahy. Effect of oxygen on misonidazole chemosensitization and cytotoxicity in vitro. , 1984, Cancer research.
[23] H. Oppelaar,et al. Changes in perfusion of mouse tumours after photodynamic therapy , 1994, International journal of cancer.
[24] D. Chaplin,et al. Intermittent blood flow in a murine tumor: radiobiological effects. , 1987, Cancer research.
[25] H. Oppelaar,et al. Photosensitizing efficacy of MTHPC‐PDT compared to Photofrin‐PDT in the RIF1 mouse tumour and normal skin , 2006, International journal of cancer.
[26] T. Foster,et al. Oxygen consumption and diffusion effects in photodynamic therapy. , 1991, Radiation research.
[27] M R Arnfield,et al. Treatment of Dunning R3327-AT rat prostate tumors with photodynamic therapy in combination with misonidazole. , 1986, Cancer research.
[28] A. Rauth,et al. Modification of the cytotoxic activity of mitomycin C by oxygen and ascorbic acid in Chinese hamster ovary cells and a repair-deficient mutant. , 1986, Cancer research.
[29] B W Henderson,et al. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. , 1987, Cancer research.
[30] H. Oppelaar,et al. Interaction of the bioreductive drug SR 4233 and photodynamic therapy using photofrin in a mouse tumor model. , 1993, International journal of radiation oncology, biology, physics.